Motilal Oswal
    NIFTY 50
Motilal Oswal

Improving company's standards and practices continuously, says DRL

Updated : March 01, 2019 10:28 AM IST

Talking about the observations received recently from the US FDA, GV Prasad of Dr Reddy's Laboratories, in an interview with CNBC-TV18, said that the pharma company was continuously trying to improve its standards and practices.

“Duvvada plant has been cleared and it is a result of the major transformation in manufacturing and quality that we achieve over the last three years. of course, as I mentioned, quality is a journey and we have to keep at it and continue to improve our standards, practices and people competencies,” said Prasad.

The company recently informed the exchanges about its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad receiving a Form 483 with 11 observations by US FDA.

"Bachupally – we are in the process of responding to the FDA’s concerns and we are in advanced stages of drafting a response and providing the information that they need,” Prasad explained.

In terms of Srikakulam facility, Reddy said, “That facility is still not yet cleared but we are addressing the concerns of the FDA. The FDA has a series of questions which we are answering.”
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV